Shiitake Mushrooms: Natural Hpv Treatment?

Human papillomavirus, or HPV, is the most common sexually transmitted infection in the United States, with no known cure or treatment. However, recent studies have shown that an extract from shiitake mushrooms called AHCC (Active Hexose Correlated Compound) may be able to eradicate HPV. AHCC is a natural extract derived from the cell wall of the mycelia of shiitake mushrooms and is available as a nutritional supplement known for its immune-boosting properties. In a study conducted on women with HPV infections, those who took AHCC daily for six months showed a significant decrease in HPV infections, with some participants completely eradicating the virus. While the results are promising, more research is needed to confirm the effectiveness of AHCC in curing HPV.

Shiitake mushroom extract may eradicate HPV

Human papillomavirus (HPV) is the most commonly transmitted sexual infection in the US. It is the main cause of cervical cancer in women, with HPV 16 and HPV 18 accounting for around 70% of cases. HPV is also responsible for 95% of anal cancers, 65% of vaginal cancers, 60% of oropharyngeal cancers, 50% of vulvar cancers, and 35% of penile cancers. While there are two HPV vaccines available to prevent infection by cancer-causing HPV subtypes, there is currently no cure for HPV and no effective treatments for the virus.

Shiitake mushroom extract, also known as AHCC (Active Hexose Correlated Compound), has been found to have potential in eradicating HPV. AHCC is a unique natural cultured extract derived from the cell wall of the mycelia of Lentitula edodes (shiitake) mushrooms, native to Asia. It is commonly sold as an over-the-counter nutritional supplement and is hailed for its immune-boosting properties.

In a pilot study conducted by Dr Judith A. Smith of the University of Texas Health Science Center at Houston, 10 women with HPV infection were given an oral formulation of AHCC once a day for up to 6 months. Five of these women tested negative for HPV infection after 3 months of AHCC use, and 3 of the participants had completely eradicated HPV after ceasing AHCC use. In another study, 63.6% of patients who received 6 months of daily AHCC treatment cleared the infection with no adverse side effects, compared to only 10.5% in the placebo group.

The mechanism behind AHCC's potential efficacy in eradicating HPV involves its ability to improve the growth and function of cells that fight off infections and prevent tumour growth. AHCC has been shown to enhance the activation of CD4 (+) and CD8 (+) T cells, as well as increase NK cells and T lymphocytes. This suggests that AHCC supplementation may support the immune system in clearing persistent HPV infections. However, it is important to note that further research is needed to confirm these findings and establish the optimal duration of AHCC supplementation for successful eradication of HPV.

AHCC boosts the immune system

AHCC (Active Hexose Correlated Compound) is a substance produced by the shiitake mushroom, also known as the Japanese mushroom, native to Asia. It is a functional food supplement that can help support and protect the immune system. It is derived from the cells of shiitake mushroom mycelia, cultured with a unique mix of nutrients for nearly two months.

AHCC has been shown to have immune-boosting properties and can improve the growth and function of cells that ward off infections and prevent tumour growth. It can increase the number of macrophages, which improves the ability of the immune system to function optimally. The activity of macrophages was demonstrated in a mouse model of breast cancer. In one study, AHCC was shown to stimulate T cell function in adults aged 50 years and older. It can also improve the balance between Th1 and Th2 cells, which are involved in activating and directing other immune system cell functions, including the activation and growth of cytotoxic lymphocytes and maximizing the activities of macrophages.

AHCC has been investigated for a variety of applications in more than 100 scientific publications. It has been studied for its potential to support the immune system in fighting the SARS-CoV-2 virus. Laboratory studies on mice have also revealed that AHCC is effective at activating immune cells against the West Nile virus, influenza, and avian flu.

AHCC has been shown to be effective in supporting the immune system to eliminate persistent HPV infections. In a pilot study of 10 women infected with HPV, three tested negative for the virus after 3 months of AHCC use, and remained clear of the virus one month after their last dose. In another study, 14 out of 22 women who received six months of daily AHCC treatment cleared the HPV infection with no adverse side effects.

HPV is a common sexually transmitted infection

Human papillomavirus, or HPV, is the most common sexually transmitted infection in the United States, affecting between 60 and 80 percent of sexually active adults. It is caused by a virus that can lead to several types of cancer, most commonly cervical cancer in women. HPV is also responsible for a large percentage of anal, vaginal, oropharyngeal, vulvar, and penile cancers. Although there are two HPV vaccines available that can help prevent infection by cancer-causing HPV subtypes, there is currently no cure for HPV and no effective treatments for the virus.

Despite the lack of a cure, recent studies have shown that an extract from shiitake mushrooms called AHCC (Active Hexose Correlated Compound) may have the potential to eradicate HPV. AHCC is a natural cultured extract derived from the cell wall of the mycelia of shiitake mushrooms and is commonly sold as an over-the-counter nutritional supplement for its immune-boosting properties. In a pilot study, 10 women with HPV were given AHCC daily for up to 6 months, and 5 of them tested negative for HPV after 3 months. Among 3 of the participants, HPV was completely eradicated even after they stopped taking AHCC.

Another study of 50 women over 30 years of age with high-risk HPV found that 14 (63.6%) of the 22 patients who took AHCC daily for 6 months cleared the infection with no adverse side effects, compared to only 2 (10.5%) of 19 patients in the placebo group. These results suggest that AHCC supplementation may be effective in supporting the immune system to clear persistent HPV infections. However, it is important to note that AHCC is not a cure for HPV, and more research is needed to fully understand its potential benefits.

While the findings on the potential benefits of AHCC in treating HPV are promising, it is important to consult a healthcare professional before taking any supplements. Additionally, it is crucial to continue following recommended cancer screening guidelines, such as cervical cancer screening, even if AHCC supplementation is being used.

HPV is a common and concerning sexually transmitted infection that can have serious health consequences. While there is currently no cure, the potential benefits of AHCC supplementation offer a glimmer of hope for those affected by HPV. Further research and clinical trials are needed to fully understand the role of AHCC in treating HPV and to develop more effective treatments for this common infection.

HPV infections can cause cancer

Human papillomavirus (HPV) is a common sexually transmitted infection that can cause several types of cancer. HPV is known to cause cancers of the mouth and throat, cervix, vulva, vagina, penis, and anus. It is estimated that HPV causes about 690,000 cancers worldwide each year, with about 350,000 women dying from cervical cancer. In the United States alone, more than 37,000 people are affected by HPV-related cancers annually.

HPV infections are typically classified as either low-risk or high-risk. Low-risk HPV types rarely cause cancer but can lead to the development of warts on or around the genitals, anus, mouth, or throat. High-risk HPV infections, on the other hand, can persist for many years and lead to cell changes that may eventually become precancerous and then cancerous. High-risk HPV is an invisible infection that can only be detected through a tissue swab, and it is the leading cause of six different types of cancer. The two most common cancers associated with high-risk HPV are cervical cancer and head-and-neck cancer.

The progression from HPV infection to cancer typically occurs when the body's immune system fails to clear the infection. Usually, the immune system can get rid of HPV within one to two years. However, in some cases, high-risk HPV infections persist and cause cell changes that can lead to cancer. These cell changes, known as precancers, may develop into cancer if not found and removed in time.

The International Agency for Research on Cancer has found that 13 HPV types can cause cervical cancer. Additionally, certain HPV types are associated with cancers of the vulva, vagina, penis, anus, and certain head and neck cancers, specifically in the oropharynx, which includes the back of the throat. It is important to note that cancers in the oropharynx are often caused by a combination of factors, including tobacco and alcohol use, in addition to HPV infection.

While there are HPV vaccines available to prevent infection and reduce the risk of cancer, they do not eliminate existing HPV infections. However, recent studies have suggested that an extract from shiitake mushrooms, known as AHCC (Active Hexose Correlated Compound), may have the potential to eradicate HPV. AHCC is a natural cultured extract derived from the cell wall of shiitake mushrooms and is known for its immune-boosting properties. In a pilot study, women who took AHCC orally for up to six months showed promising results in clearing HPV infections, providing a potential new approach to treating HPV and reducing the risk of HPV-related cancers.

There is no cure for HPV

Human papillomavirus, or HPV, is the most common sexually transmitted infection in the United States, affecting between 60 and 80 percent of sexually active adults. Despite its prevalence, there is currently no cure for HPV. While vaccines can prevent infection by cancer-causing HPV subtypes, they do not eliminate the virus from the body.

Most people with healthy immune systems will eliminate high-risk HPV infections within 6 to 18 months without any interventions. However, for those with persistent HPV infections, there are limited effective options for clearing the virus. Current treatments include invasive procedures or local topical treatments, but these do not necessarily prevent the virus from returning or spreading to other areas of the body.

While there is no cure for HPV, recent studies have shown that an extract derived from shiitake mushrooms, called AHCC, may be a potential treatment option. AHCC is a natural cultured extract derived from the cell wall of shiitake mushrooms and is available as a nutritional supplement. It has been shown to boost the immune system and may help eradicate HPV.

In one study, 10 women with HPV were given AHCC daily for up to 6 months. Five of these women tested negative for HPV after 3 months, and 3 women remained clear of the virus one month after discontinuing AHCC use. Another study of 34 women found that 63.6% of those who received 6 months of daily AHCC treatment cleared the HPV infection with no adverse side effects.

While these findings are promising, more research is needed to confirm the effectiveness of AHCC in treating HPV. It is important to consult with a healthcare professional before taking any supplements, as individual results may vary.

Frequently asked questions